
|Articles|August 25, 2020
Inspire Announces Inspire Research Accelerator Initiative
Advertisement
Inspire Founder/CEO Brian Loew has announced a new initiative, the Inspire Research Accelerator, a program that aims to accelerate medical progress by enabling academic researchers around the world—at no cost—to collaborate with Inspire.
“The Accelerator’s goal is to enable scientific discovery by connecting researchers with patients, especially those affected by rare diseases,” Loew said.
The Accelerator will aim to help propel research in a variety of ways:
- Unlocking research gaps using longitudinal instruments, especially for personalized medicine and rare diseases
- Identifying and engaging with cancer and rare disease patient populations based on specific clinical trials experience and interest
- Rapidly deploying validated Patient-Reported Outcome (PRO) measurement tools
- Furthering exploration of complex disease underpinnings by correlating structured and unstructured data and phenotypes reported by patients with other data types such as genomics/multi-omics and other biological data
Read the full release,
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
3
A Shot in the Arm to Traditional Vaccine Trial Strategy
4
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
5



